ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-tuberculosis APIs Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-1E19189
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti tuberculosis APIs Market Research Report 2025
BUY CHAPTERS

Global Anti-tuberculosis APIs Market Research Report 2025

Code: QYRE-Auto-1E19189
Report
March 2025
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TB
Calyx Chemicals and Pharmaceuticals Ltd.
Linaria Chemicals (Thailand) Ltd
Minakem
Lupin Ltd
Anuh Pharma LTD
Macleods Pharmaceuticals Ltd
Amsal Chem Private Limited
Taizhou Tianrui Pharmaceutical Co.,Ltd.
Zhejiang Haizhou Pharmaceutical Co., Ltd.
Chongqing Huapont Pharmaceutical Co. Ltd
Tonglian Group
Guangan Bingde Pharmaceutical Co., LTD.
Hebei Xingang Pharmaceutical Co., Ltd.
Luohe Chief Pharmaceutical Co, Ltd.
Zhengzhou Minzhong Pharmaceutical Co., Ltd
China Res Double-Crane Pharmaceutical
Tianjin Handewei Pharmaceutical Co.,Ltd
Yuki Gosei Kogyo Co., Ltd.
Shanghai New Asia Pharmaceutical Co. Ltd.
Suzhou Fifth Pharmaceutical Factory Co.
Maneesh Pharmaceuticals Ltd
Wuhan Wuyao Pharmaceutical Co., Ltd
Cadila Pharmaceuticals
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
PKU HealthCare Corp., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Godavari Drugs Limited
Camus pharma

Anti-tuberculosis APIs Market Size

The global market for Anti-tuberculosis APIs was valued at US$ 271 million in the year 2024 and is projected to reach a revised size of US$ 526 million by 2031, growing at a CAGR of 10.0% during the forecast period.

Anti-tuberculosis APIs Market

Anti-tuberculosis APIs Market

Anti-tuberculosis APIs are active pharmaceutical ingredients (APIs) used in the treatment of tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis. These APIs are classified into first-line and second-line drugs, depending on their effectiveness and resistance profile.
North American market for Anti-tuberculosis APIs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-tuberculosis APIs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Anti-tuberculosis APIs include Calyx Chemicals and Pharmaceuticals Ltd., Linaria Chemicals (Thailand) Ltd, Minakem, Lupin Limited, Anuh Pharma Ltd., Macleods Pharmaceuticals Ltd., Amsal Chem Private Limited, Taizhou Tianrui Pharmaceutical Co.,Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Chongqing Huapont Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-tuberculosis APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-tuberculosis APIs.
The Anti-tuberculosis APIs market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-tuberculosis APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-tuberculosis APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-tuberculosis APIs Market Report

Report Metric Details
Report Name Anti-tuberculosis APIs Market
Accounted market size in year US$ 271 million
Forecasted market size in 2031 US$ 526 million
CAGR 10.0%
Base Year year
Forecasted years 2025 - 2031
by Type
by Application
  • Tablets
  • Capsules
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Calyx Chemicals and Pharmaceuticals Ltd., Linaria Chemicals (Thailand) Ltd, Minakem, Lupin Limited, Anuh Pharma Ltd., Macleods Pharmaceuticals Ltd., Amsal Chem Private Limited, Taizhou Tianrui Pharmaceutical Co.,Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Chongqing Huapont Pharmaceutical Co., Ltd., Tonglian Group, Guangan Bingde Pharmaceutical Co., LTD., Hebei Xingang Pharmaceutical Co., Ltd., Luohe Chief Pharmaceutical Co, Ltd., Zhengzhou Minzhong Pharmaceutical Co., Ltd., China Res Double-Crane Pharmaceutical, Tianjin Handewei Pharmaceutical Co.,Ltd, YUKI GOSEI KOGYO CO.,LTD, Shanghai New Asia Pharmaceutical Co. Ltd., Suzhou Fifth Pharmaceutical Factory Co., Maneesh Pharmaceuticals Ltd., Wuhan Wuyao Pharmaceutical Co., Ltd., Cadila Pharmaceuticals, Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd., PKU HealthCare Corp., Ltd., Northeast Pharmaceutical Group Co., Ltd., Godavari Drugs Limited, Camus Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-tuberculosis APIs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Anti-tuberculosis APIs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Anti-tuberculosis APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-tuberculosis APIs Market growing?

Ans: The Anti-tuberculosis APIs Market witnessing a CAGR of 10.0% during the forecast period 2025-2031.

What is the Anti-tuberculosis APIs Market size in 2031?

Ans: The Anti-tuberculosis APIs Market size in 2031 will be US$ 526 million.

Who are the main players in the Anti-tuberculosis APIs Market report?

Ans: The main players in the Anti-tuberculosis APIs Market are Calyx Chemicals and Pharmaceuticals Ltd., Linaria Chemicals (Thailand) Ltd, Minakem, Lupin Limited, Anuh Pharma Ltd., Macleods Pharmaceuticals Ltd., Amsal Chem Private Limited, Taizhou Tianrui Pharmaceutical Co.,Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Chongqing Huapont Pharmaceutical Co., Ltd., Tonglian Group, Guangan Bingde Pharmaceutical Co., LTD., Hebei Xingang Pharmaceutical Co., Ltd., Luohe Chief Pharmaceutical Co, Ltd., Zhengzhou Minzhong Pharmaceutical Co., Ltd., China Res Double-Crane Pharmaceutical, Tianjin Handewei Pharmaceutical Co.,Ltd, YUKI GOSEI KOGYO CO.,LTD, Shanghai New Asia Pharmaceutical Co. Ltd., Suzhou Fifth Pharmaceutical Factory Co., Maneesh Pharmaceuticals Ltd., Wuhan Wuyao Pharmaceutical Co., Ltd., Cadila Pharmaceuticals, Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd., PKU HealthCare Corp., Ltd., Northeast Pharmaceutical Group Co., Ltd., Godavari Drugs Limited, Camus Pharma

What are the Application segmentation covered in the Anti-tuberculosis APIs Market report?

Ans: The Applications covered in the Anti-tuberculosis APIs Market report are Tablets, Capsules, Other

What are the Type segmentation covered in the Anti-tuberculosis APIs Market report?

Ans: The Types covered in the Anti-tuberculosis APIs Market report are Pyrazinamide APIs, Isoniazid APIs, Rifampicin APIs, Ethambutol HCL APIs, Other

Recommended Reports

Pharmaceutical APIs

Anti-Infective APIs

Tuberculosis Markets

1 Anti-tuberculosis APIs Market Overview
1.1 Product Definition
1.2 Anti-tuberculosis APIs by Type
1.2.1 Global Anti-tuberculosis APIs Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Pyrazinamide APIs
1.2.3 Isoniazid APIs
1.2.4 Rifampicin APIs
1.2.5 Ethambutol HCL APIs
1.2.6 Other
1.3 Anti-tuberculosis APIs by Application
1.3.1 Global Anti-tuberculosis APIs Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Anti-tuberculosis APIs Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Anti-tuberculosis APIs Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Anti-tuberculosis APIs Production Estimates and Forecasts (2020-2031)
1.4.4 Global Anti-tuberculosis APIs Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Anti-tuberculosis APIs Production Market Share by Manufacturers (2020-2025)
2.2 Global Anti-tuberculosis APIs Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Anti-tuberculosis APIs, Industry Ranking, 2023 VS 2024
2.4 Global Anti-tuberculosis APIs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Anti-tuberculosis APIs Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Anti-tuberculosis APIs, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Anti-tuberculosis APIs, Product Offered and Application
2.8 Global Key Manufacturers of Anti-tuberculosis APIs, Date of Enter into This Industry
2.9 Anti-tuberculosis APIs Market Competitive Situation and Trends
2.9.1 Anti-tuberculosis APIs Market Concentration Rate
2.9.2 Global 5 and 10 Largest Anti-tuberculosis APIs Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Anti-tuberculosis APIs Production by Region
3.1 Global Anti-tuberculosis APIs Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Anti-tuberculosis APIs Production Value by Region (2020-2031)
3.2.1 Global Anti-tuberculosis APIs Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Anti-tuberculosis APIs by Region (2026-2031)
3.3 Global Anti-tuberculosis APIs Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Anti-tuberculosis APIs Production Volume by Region (2020-2031)
3.4.1 Global Anti-tuberculosis APIs Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Anti-tuberculosis APIs by Region (2026-2031)
3.5 Global Anti-tuberculosis APIs Market Price Analysis by Region (2020-2025)
3.6 Global Anti-tuberculosis APIs Production and Value, Year-over-Year Growth
3.6.1 North America Anti-tuberculosis APIs Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Anti-tuberculosis APIs Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Anti-tuberculosis APIs Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Anti-tuberculosis APIs Production Value Estimates and Forecasts (2020-2031)
4 Anti-tuberculosis APIs Consumption by Region
4.1 Global Anti-tuberculosis APIs Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Anti-tuberculosis APIs Consumption by Region (2020-2031)
4.2.1 Global Anti-tuberculosis APIs Consumption by Region (2020-2025)
4.2.2 Global Anti-tuberculosis APIs Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Anti-tuberculosis APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Anti-tuberculosis APIs Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Anti-tuberculosis APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Anti-tuberculosis APIs Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Anti-tuberculosis APIs Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Anti-tuberculosis APIs Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Anti-tuberculosis APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Anti-tuberculosis APIs Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Anti-tuberculosis APIs Production by Type (2020-2031)
5.1.1 Global Anti-tuberculosis APIs Production by Type (2020-2025)
5.1.2 Global Anti-tuberculosis APIs Production by Type (2026-2031)
5.1.3 Global Anti-tuberculosis APIs Production Market Share by Type (2020-2031)
5.2 Global Anti-tuberculosis APIs Production Value by Type (2020-2031)
5.2.1 Global Anti-tuberculosis APIs Production Value by Type (2020-2025)
5.2.2 Global Anti-tuberculosis APIs Production Value by Type (2026-2031)
5.2.3 Global Anti-tuberculosis APIs Production Value Market Share by Type (2020-2031)
5.3 Global Anti-tuberculosis APIs Price by Type (2020-2031)
6 Segment by Application
6.1 Global Anti-tuberculosis APIs Production by Application (2020-2031)
6.1.1 Global Anti-tuberculosis APIs Production by Application (2020-2025)
6.1.2 Global Anti-tuberculosis APIs Production by Application (2026-2031)
6.1.3 Global Anti-tuberculosis APIs Production Market Share by Application (2020-2031)
6.2 Global Anti-tuberculosis APIs Production Value by Application (2020-2031)
6.2.1 Global Anti-tuberculosis APIs Production Value by Application (2020-2025)
6.2.2 Global Anti-tuberculosis APIs Production Value by Application (2026-2031)
6.2.3 Global Anti-tuberculosis APIs Production Value Market Share by Application (2020-2031)
6.3 Global Anti-tuberculosis APIs Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Calyx Chemicals and Pharmaceuticals Ltd.
7.1.1 Calyx Chemicals and Pharmaceuticals Ltd. Anti-tuberculosis APIs Company Information
7.1.2 Calyx Chemicals and Pharmaceuticals Ltd. Anti-tuberculosis APIs Product Portfolio
7.1.3 Calyx Chemicals and Pharmaceuticals Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Calyx Chemicals and Pharmaceuticals Ltd. Main Business and Markets Served
7.1.5 Calyx Chemicals and Pharmaceuticals Ltd. Recent Developments/Updates
7.2 Linaria Chemicals (Thailand) Ltd
7.2.1 Linaria Chemicals (Thailand) Ltd Anti-tuberculosis APIs Company Information
7.2.2 Linaria Chemicals (Thailand) Ltd Anti-tuberculosis APIs Product Portfolio
7.2.3 Linaria Chemicals (Thailand) Ltd Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Linaria Chemicals (Thailand) Ltd Main Business and Markets Served
7.2.5 Linaria Chemicals (Thailand) Ltd Recent Developments/Updates
7.3 Minakem
7.3.1 Minakem Anti-tuberculosis APIs Company Information
7.3.2 Minakem Anti-tuberculosis APIs Product Portfolio
7.3.3 Minakem Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Minakem Main Business and Markets Served
7.3.5 Minakem Recent Developments/Updates
7.4 Lupin Limited
7.4.1 Lupin Limited Anti-tuberculosis APIs Company Information
7.4.2 Lupin Limited Anti-tuberculosis APIs Product Portfolio
7.4.3 Lupin Limited Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Lupin Limited Main Business and Markets Served
7.4.5 Lupin Limited Recent Developments/Updates
7.5 Anuh Pharma Ltd.
7.5.1 Anuh Pharma Ltd. Anti-tuberculosis APIs Company Information
7.5.2 Anuh Pharma Ltd. Anti-tuberculosis APIs Product Portfolio
7.5.3 Anuh Pharma Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Anuh Pharma Ltd. Main Business and Markets Served
7.5.5 Anuh Pharma Ltd. Recent Developments/Updates
7.6 Macleods Pharmaceuticals Ltd.
7.6.1 Macleods Pharmaceuticals Ltd. Anti-tuberculosis APIs Company Information
7.6.2 Macleods Pharmaceuticals Ltd. Anti-tuberculosis APIs Product Portfolio
7.6.3 Macleods Pharmaceuticals Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Macleods Pharmaceuticals Ltd. Main Business and Markets Served
7.6.5 Macleods Pharmaceuticals Ltd. Recent Developments/Updates
7.7 Amsal Chem Private Limited
7.7.1 Amsal Chem Private Limited Anti-tuberculosis APIs Company Information
7.7.2 Amsal Chem Private Limited Anti-tuberculosis APIs Product Portfolio
7.7.3 Amsal Chem Private Limited Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Amsal Chem Private Limited Main Business and Markets Served
7.7.5 Amsal Chem Private Limited Recent Developments/Updates
7.8 Taizhou Tianrui Pharmaceutical Co.,Ltd.
7.8.1 Taizhou Tianrui Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Company Information
7.8.2 Taizhou Tianrui Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Product Portfolio
7.8.3 Taizhou Tianrui Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Taizhou Tianrui Pharmaceutical Co.,Ltd. Main Business and Markets Served
7.8.5 Taizhou Tianrui Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.9 Zhejiang Haizhou Pharmaceutical Co., Ltd.
7.9.1 Zhejiang Haizhou Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
7.9.2 Zhejiang Haizhou Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Product Portfolio
7.9.3 Zhejiang Haizhou Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Zhejiang Haizhou Pharmaceutical Co., Ltd. Main Business and Markets Served
7.9.5 Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments/Updates
7.10 Chongqing Huapont Pharmaceutical Co., Ltd.
7.10.1 Chongqing Huapont Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
7.10.2 Chongqing Huapont Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Product Portfolio
7.10.3 Chongqing Huapont Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Chongqing Huapont Pharmaceutical Co., Ltd. Main Business and Markets Served
7.10.5 Chongqing Huapont Pharmaceutical Co., Ltd. Recent Developments/Updates
7.11 Tonglian Group
7.11.1 Tonglian Group Anti-tuberculosis APIs Company Information
7.11.2 Tonglian Group Anti-tuberculosis APIs Product Portfolio
7.11.3 Tonglian Group Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Tonglian Group Main Business and Markets Served
7.11.5 Tonglian Group Recent Developments/Updates
7.12 Guangan Bingde Pharmaceutical Co., LTD.
7.12.1 Guangan Bingde Pharmaceutical Co., LTD. Anti-tuberculosis APIs Company Information
7.12.2 Guangan Bingde Pharmaceutical Co., LTD. Anti-tuberculosis APIs Product Portfolio
7.12.3 Guangan Bingde Pharmaceutical Co., LTD. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Guangan Bingde Pharmaceutical Co., LTD. Main Business and Markets Served
7.12.5 Guangan Bingde Pharmaceutical Co., LTD. Recent Developments/Updates
7.13 Hebei Xingang Pharmaceutical Co., Ltd.
7.13.1 Hebei Xingang Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
7.13.2 Hebei Xingang Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Product Portfolio
7.13.3 Hebei Xingang Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Hebei Xingang Pharmaceutical Co., Ltd. Main Business and Markets Served
7.13.5 Hebei Xingang Pharmaceutical Co., Ltd. Recent Developments/Updates
7.14 Luohe Chief Pharmaceutical Co, Ltd.
7.14.1 Luohe Chief Pharmaceutical Co, Ltd. Anti-tuberculosis APIs Company Information
7.14.2 Luohe Chief Pharmaceutical Co, Ltd. Anti-tuberculosis APIs Product Portfolio
7.14.3 Luohe Chief Pharmaceutical Co, Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Luohe Chief Pharmaceutical Co, Ltd. Main Business and Markets Served
7.14.5 Luohe Chief Pharmaceutical Co, Ltd. Recent Developments/Updates
7.15 Zhengzhou Minzhong Pharmaceutical Co., Ltd.
7.15.1 Zhengzhou Minzhong Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
7.15.2 Zhengzhou Minzhong Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Product Portfolio
7.15.3 Zhengzhou Minzhong Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Zhengzhou Minzhong Pharmaceutical Co., Ltd. Main Business and Markets Served
7.15.5 Zhengzhou Minzhong Pharmaceutical Co., Ltd. Recent Developments/Updates
7.16 China Res Double-Crane Pharmaceutical
7.16.1 China Res Double-Crane Pharmaceutical Anti-tuberculosis APIs Company Information
7.16.2 China Res Double-Crane Pharmaceutical Anti-tuberculosis APIs Product Portfolio
7.16.3 China Res Double-Crane Pharmaceutical Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.16.4 China Res Double-Crane Pharmaceutical Main Business and Markets Served
7.16.5 China Res Double-Crane Pharmaceutical Recent Developments/Updates
7.17 Tianjin Handewei Pharmaceutical Co.,Ltd
7.17.1 Tianjin Handewei Pharmaceutical Co.,Ltd Anti-tuberculosis APIs Company Information
7.17.2 Tianjin Handewei Pharmaceutical Co.,Ltd Anti-tuberculosis APIs Product Portfolio
7.17.3 Tianjin Handewei Pharmaceutical Co.,Ltd Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Tianjin Handewei Pharmaceutical Co.,Ltd Main Business and Markets Served
7.17.5 Tianjin Handewei Pharmaceutical Co.,Ltd Recent Developments/Updates
7.18 YUKI GOSEI KOGYO CO.,LTD
7.18.1 YUKI GOSEI KOGYO CO.,LTD Anti-tuberculosis APIs Company Information
7.18.2 YUKI GOSEI KOGYO CO.,LTD Anti-tuberculosis APIs Product Portfolio
7.18.3 YUKI GOSEI KOGYO CO.,LTD Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.18.4 YUKI GOSEI KOGYO CO.,LTD Main Business and Markets Served
7.18.5 YUKI GOSEI KOGYO CO.,LTD Recent Developments/Updates
7.19 Shanghai New Asia Pharmaceutical Co. Ltd.
7.19.1 Shanghai New Asia Pharmaceutical Co. Ltd. Anti-tuberculosis APIs Company Information
7.19.2 Shanghai New Asia Pharmaceutical Co. Ltd. Anti-tuberculosis APIs Product Portfolio
7.19.3 Shanghai New Asia Pharmaceutical Co. Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Shanghai New Asia Pharmaceutical Co. Ltd. Main Business and Markets Served
7.19.5 Shanghai New Asia Pharmaceutical Co. Ltd. Recent Developments/Updates
7.20 Suzhou Fifth Pharmaceutical Factory Co.
7.20.1 Suzhou Fifth Pharmaceutical Factory Co. Anti-tuberculosis APIs Company Information
7.20.2 Suzhou Fifth Pharmaceutical Factory Co. Anti-tuberculosis APIs Product Portfolio
7.20.3 Suzhou Fifth Pharmaceutical Factory Co. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Suzhou Fifth Pharmaceutical Factory Co. Main Business and Markets Served
7.20.5 Suzhou Fifth Pharmaceutical Factory Co. Recent Developments/Updates
7.21 Maneesh Pharmaceuticals Ltd.
7.21.1 Maneesh Pharmaceuticals Ltd. Anti-tuberculosis APIs Company Information
7.21.2 Maneesh Pharmaceuticals Ltd. Anti-tuberculosis APIs Product Portfolio
7.21.3 Maneesh Pharmaceuticals Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Maneesh Pharmaceuticals Ltd. Main Business and Markets Served
7.21.5 Maneesh Pharmaceuticals Ltd. Recent Developments/Updates
7.22 Wuhan Wuyao Pharmaceutical Co., Ltd.
7.22.1 Wuhan Wuyao Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
7.22.2 Wuhan Wuyao Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Product Portfolio
7.22.3 Wuhan Wuyao Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.22.4 Wuhan Wuyao Pharmaceutical Co., Ltd. Main Business and Markets Served
7.22.5 Wuhan Wuyao Pharmaceutical Co., Ltd. Recent Developments/Updates
7.23 Cadila Pharmaceuticals
7.23.1 Cadila Pharmaceuticals Anti-tuberculosis APIs Company Information
7.23.2 Cadila Pharmaceuticals Anti-tuberculosis APIs Product Portfolio
7.23.3 Cadila Pharmaceuticals Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.23.4 Cadila Pharmaceuticals Main Business and Markets Served
7.23.5 Cadila Pharmaceuticals Recent Developments/Updates
7.24 Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd.
7.24.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Company Information
7.24.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Product Portfolio
7.24.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.24.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Main Business and Markets Served
7.24.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.25 PKU HealthCare Corp., Ltd.
7.25.1 PKU HealthCare Corp., Ltd. Anti-tuberculosis APIs Company Information
7.25.2 PKU HealthCare Corp., Ltd. Anti-tuberculosis APIs Product Portfolio
7.25.3 PKU HealthCare Corp., Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.25.4 PKU HealthCare Corp., Ltd. Main Business and Markets Served
7.25.5 PKU HealthCare Corp., Ltd. Recent Developments/Updates
7.26 Northeast Pharmaceutical Group Co., Ltd.
7.26.1 Northeast Pharmaceutical Group Co., Ltd. Anti-tuberculosis APIs Company Information
7.26.2 Northeast Pharmaceutical Group Co., Ltd. Anti-tuberculosis APIs Product Portfolio
7.26.3 Northeast Pharmaceutical Group Co., Ltd. Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.26.4 Northeast Pharmaceutical Group Co., Ltd. Main Business and Markets Served
7.26.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7.27 Godavari Drugs Limited
7.27.1 Godavari Drugs Limited Anti-tuberculosis APIs Company Information
7.27.2 Godavari Drugs Limited Anti-tuberculosis APIs Product Portfolio
7.27.3 Godavari Drugs Limited Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.27.4 Godavari Drugs Limited Main Business and Markets Served
7.27.5 Godavari Drugs Limited Recent Developments/Updates
7.28 Camus Pharma
7.28.1 Camus Pharma Anti-tuberculosis APIs Company Information
7.28.2 Camus Pharma Anti-tuberculosis APIs Product Portfolio
7.28.3 Camus Pharma Anti-tuberculosis APIs Production, Value, Price and Gross Margin (2020-2025)
7.28.4 Camus Pharma Main Business and Markets Served
7.28.5 Camus Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Anti-tuberculosis APIs Industry Chain Analysis
8.2 Anti-tuberculosis APIs Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Anti-tuberculosis APIs Production Mode & Process Analysis
8.4 Anti-tuberculosis APIs Sales and Marketing
8.4.1 Anti-tuberculosis APIs Sales Channels
8.4.2 Anti-tuberculosis APIs Distributors
8.5 Anti-tuberculosis APIs Customer Analysis
9 Anti-tuberculosis APIs Market Dynamics
9.1 Anti-tuberculosis APIs Industry Trends
9.2 Anti-tuberculosis APIs Market Drivers
9.3 Anti-tuberculosis APIs Market Challenges
9.4 Anti-tuberculosis APIs Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
TB
Calyx Chemicals and Pharmaceuticals Ltd.
Linaria Chemicals (Thailand) Ltd
Minakem
Lupin Ltd
Anuh Pharma LTD
Macleods Pharmaceuticals Ltd
Amsal Chem Private Limited
Taizhou Tianrui Pharmaceutical Co.,Ltd.
Zhejiang Haizhou Pharmaceutical Co., Ltd.
Chongqing Huapont Pharmaceutical Co. Ltd
Tonglian Group
Guangan Bingde Pharmaceutical Co., LTD.
Hebei Xingang Pharmaceutical Co., Ltd.
Luohe Chief Pharmaceutical Co, Ltd.
Zhengzhou Minzhong Pharmaceutical Co., Ltd
China Res Double-Crane Pharmaceutical
Tianjin Handewei Pharmaceutical Co.,Ltd
Yuki Gosei Kogyo Co., Ltd.
Shanghai New Asia Pharmaceutical Co. Ltd.
Suzhou Fifth Pharmaceutical Factory Co.
Maneesh Pharmaceuticals Ltd
Wuhan Wuyao Pharmaceutical Co., Ltd
Cadila Pharmaceuticals
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
PKU HealthCare Corp., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Godavari Drugs Limited
Camus pharma
List of Tables
 Table 1. Global Anti-tuberculosis APIs Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Anti-tuberculosis APIs Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Anti-tuberculosis APIs Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Anti-tuberculosis APIs Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Anti-tuberculosis APIs Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-tuberculosis APIs Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Anti-tuberculosis APIs Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Anti-tuberculosis APIs, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Anti-tuberculosis APIs as of 2024)
 Table 10. Global Market Anti-tuberculosis APIs Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Anti-tuberculosis APIs, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Anti-tuberculosis APIs, Product Offered and Application
 Table 13. Global Key Manufacturers of Anti-tuberculosis APIs, Date of Enter into This Industry
 Table 14. Global Anti-tuberculosis APIs Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-tuberculosis APIs Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Anti-tuberculosis APIs Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Anti-tuberculosis APIs Production Value Market Share by Region (2020-2025)
 Table 19. Global Anti-tuberculosis APIs Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Anti-tuberculosis APIs Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Anti-tuberculosis APIs Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Anti-tuberculosis APIs Production (Tons) by Region (2020-2025)
 Table 23. Global Anti-tuberculosis APIs Production Market Share by Region (2020-2025)
 Table 24. Global Anti-tuberculosis APIs Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Anti-tuberculosis APIs Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Anti-tuberculosis APIs Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Anti-tuberculosis APIs Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Anti-tuberculosis APIs Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Anti-tuberculosis APIs Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Anti-tuberculosis APIs Consumption Market Share by Region (2020-2025)
 Table 31. Global Anti-tuberculosis APIs Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Anti-tuberculosis APIs Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Anti-tuberculosis APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Anti-tuberculosis APIs Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Anti-tuberculosis APIs Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Anti-tuberculosis APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Anti-tuberculosis APIs Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Anti-tuberculosis APIs Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Anti-tuberculosis APIs Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Anti-tuberculosis APIs Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Anti-tuberculosis APIs Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Anti-tuberculosis APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Anti-tuberculosis APIs Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Anti-tuberculosis APIs Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Anti-tuberculosis APIs Production (Tons) by Type (2020-2025)
 Table 46. Global Anti-tuberculosis APIs Production (Tons) by Type (2026-2031)
 Table 47. Global Anti-tuberculosis APIs Production Market Share by Type (2020-2025)
 Table 48. Global Anti-tuberculosis APIs Production Market Share by Type (2026-2031)
 Table 49. Global Anti-tuberculosis APIs Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Anti-tuberculosis APIs Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Anti-tuberculosis APIs Production Value Market Share by Type (2020-2025)
 Table 52. Global Anti-tuberculosis APIs Production Value Market Share by Type (2026-2031)
 Table 53. Global Anti-tuberculosis APIs Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Anti-tuberculosis APIs Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Anti-tuberculosis APIs Production (Tons) by Application (2020-2025)
 Table 56. Global Anti-tuberculosis APIs Production (Tons) by Application (2026-2031)
 Table 57. Global Anti-tuberculosis APIs Production Market Share by Application (2020-2025)
 Table 58. Global Anti-tuberculosis APIs Production Market Share by Application (2026-2031)
 Table 59. Global Anti-tuberculosis APIs Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Anti-tuberculosis APIs Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Anti-tuberculosis APIs Production Value Market Share by Application (2020-2025)
 Table 62. Global Anti-tuberculosis APIs Production Value Market Share by Application (2026-2031)
 Table 63. Global Anti-tuberculosis APIs Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Anti-tuberculosis APIs Price (US$/Ton) by Application (2026-2031)
 Table 65. Calyx Chemicals and Pharmaceuticals Ltd. Anti-tuberculosis APIs Company Information
 Table 66. Calyx Chemicals and Pharmaceuticals Ltd. Anti-tuberculosis APIs Specification and Application
 Table 67. Calyx Chemicals and Pharmaceuticals Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Calyx Chemicals and Pharmaceuticals Ltd. Main Business and Markets Served
 Table 69. Calyx Chemicals and Pharmaceuticals Ltd. Recent Developments/Updates
 Table 70. Linaria Chemicals (Thailand) Ltd Anti-tuberculosis APIs Company Information
 Table 71. Linaria Chemicals (Thailand) Ltd Anti-tuberculosis APIs Specification and Application
 Table 72. Linaria Chemicals (Thailand) Ltd Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Linaria Chemicals (Thailand) Ltd Main Business and Markets Served
 Table 74. Linaria Chemicals (Thailand) Ltd Recent Developments/Updates
 Table 75. Minakem Anti-tuberculosis APIs Company Information
 Table 76. Minakem Anti-tuberculosis APIs Specification and Application
 Table 77. Minakem Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Minakem Main Business and Markets Served
 Table 79. Minakem Recent Developments/Updates
 Table 80. Lupin Limited Anti-tuberculosis APIs Company Information
 Table 81. Lupin Limited Anti-tuberculosis APIs Specification and Application
 Table 82. Lupin Limited Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Lupin Limited Main Business and Markets Served
 Table 84. Lupin Limited Recent Developments/Updates
 Table 85. Anuh Pharma Ltd. Anti-tuberculosis APIs Company Information
 Table 86. Anuh Pharma Ltd. Anti-tuberculosis APIs Specification and Application
 Table 87. Anuh Pharma Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Anuh Pharma Ltd. Main Business and Markets Served
 Table 89. Anuh Pharma Ltd. Recent Developments/Updates
 Table 90. Macleods Pharmaceuticals Ltd. Anti-tuberculosis APIs Company Information
 Table 91. Macleods Pharmaceuticals Ltd. Anti-tuberculosis APIs Specification and Application
 Table 92. Macleods Pharmaceuticals Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Macleods Pharmaceuticals Ltd. Main Business and Markets Served
 Table 94. Macleods Pharmaceuticals Ltd. Recent Developments/Updates
 Table 95. Amsal Chem Private Limited Anti-tuberculosis APIs Company Information
 Table 96. Amsal Chem Private Limited Anti-tuberculosis APIs Specification and Application
 Table 97. Amsal Chem Private Limited Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Amsal Chem Private Limited Main Business and Markets Served
 Table 99. Amsal Chem Private Limited Recent Developments/Updates
 Table 100. Taizhou Tianrui Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Company Information
 Table 101. Taizhou Tianrui Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Specification and Application
 Table 102. Taizhou Tianrui Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Taizhou Tianrui Pharmaceutical Co.,Ltd. Main Business and Markets Served
 Table 104. Taizhou Tianrui Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 105. Zhejiang Haizhou Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
 Table 106. Zhejiang Haizhou Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Specification and Application
 Table 107. Zhejiang Haizhou Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Zhejiang Haizhou Pharmaceutical Co., Ltd. Main Business and Markets Served
 Table 109. Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Chongqing Huapont Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
 Table 111. Chongqing Huapont Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Specification and Application
 Table 112. Chongqing Huapont Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Chongqing Huapont Pharmaceutical Co., Ltd. Main Business and Markets Served
 Table 114. Chongqing Huapont Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Tonglian Group Anti-tuberculosis APIs Company Information
 Table 116. Tonglian Group Anti-tuberculosis APIs Specification and Application
 Table 117. Tonglian Group Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Tonglian Group Main Business and Markets Served
 Table 119. Tonglian Group Recent Developments/Updates
 Table 120. Guangan Bingde Pharmaceutical Co., LTD. Anti-tuberculosis APIs Company Information
 Table 121. Guangan Bingde Pharmaceutical Co., LTD. Anti-tuberculosis APIs Specification and Application
 Table 122. Guangan Bingde Pharmaceutical Co., LTD. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Guangan Bingde Pharmaceutical Co., LTD. Main Business and Markets Served
 Table 124. Guangan Bingde Pharmaceutical Co., LTD. Recent Developments/Updates
 Table 125. Hebei Xingang Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
 Table 126. Hebei Xingang Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Specification and Application
 Table 127. Hebei Xingang Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Hebei Xingang Pharmaceutical Co., Ltd. Main Business and Markets Served
 Table 129. Hebei Xingang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Luohe Chief Pharmaceutical Co, Ltd. Anti-tuberculosis APIs Company Information
 Table 131. Luohe Chief Pharmaceutical Co, Ltd. Anti-tuberculosis APIs Specification and Application
 Table 132. Luohe Chief Pharmaceutical Co, Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Luohe Chief Pharmaceutical Co, Ltd. Main Business and Markets Served
 Table 134. Luohe Chief Pharmaceutical Co, Ltd. Recent Developments/Updates
 Table 135. Zhengzhou Minzhong Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
 Table 136. Zhengzhou Minzhong Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Specification and Application
 Table 137. Zhengzhou Minzhong Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Zhengzhou Minzhong Pharmaceutical Co., Ltd. Main Business and Markets Served
 Table 139. Zhengzhou Minzhong Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. China Res Double-Crane Pharmaceutical Anti-tuberculosis APIs Company Information
 Table 141. China Res Double-Crane Pharmaceutical Anti-tuberculosis APIs Specification and Application
 Table 142. China Res Double-Crane Pharmaceutical Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 143. China Res Double-Crane Pharmaceutical Main Business and Markets Served
 Table 144. China Res Double-Crane Pharmaceutical Recent Developments/Updates
 Table 145. Tianjin Handewei Pharmaceutical Co.,Ltd Anti-tuberculosis APIs Company Information
 Table 146. Tianjin Handewei Pharmaceutical Co.,Ltd Anti-tuberculosis APIs Specification and Application
 Table 147. Tianjin Handewei Pharmaceutical Co.,Ltd Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 148. Tianjin Handewei Pharmaceutical Co.,Ltd Main Business and Markets Served
 Table 149. Tianjin Handewei Pharmaceutical Co.,Ltd Recent Developments/Updates
 Table 150. YUKI GOSEI KOGYO CO.,LTD Anti-tuberculosis APIs Company Information
 Table 151. YUKI GOSEI KOGYO CO.,LTD Anti-tuberculosis APIs Specification and Application
 Table 152. YUKI GOSEI KOGYO CO.,LTD Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 153. YUKI GOSEI KOGYO CO.,LTD Main Business and Markets Served
 Table 154. YUKI GOSEI KOGYO CO.,LTD Recent Developments/Updates
 Table 155. Shanghai New Asia Pharmaceutical Co. Ltd. Anti-tuberculosis APIs Company Information
 Table 156. Shanghai New Asia Pharmaceutical Co. Ltd. Anti-tuberculosis APIs Specification and Application
 Table 157. Shanghai New Asia Pharmaceutical Co. Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 158. Shanghai New Asia Pharmaceutical Co. Ltd. Main Business and Markets Served
 Table 159. Shanghai New Asia Pharmaceutical Co. Ltd. Recent Developments/Updates
 Table 160. Suzhou Fifth Pharmaceutical Factory Co. Anti-tuberculosis APIs Company Information
 Table 161. Suzhou Fifth Pharmaceutical Factory Co. Anti-tuberculosis APIs Specification and Application
 Table 162. Suzhou Fifth Pharmaceutical Factory Co. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 163. Suzhou Fifth Pharmaceutical Factory Co. Main Business and Markets Served
 Table 164. Suzhou Fifth Pharmaceutical Factory Co. Recent Developments/Updates
 Table 165. Maneesh Pharmaceuticals Ltd. Anti-tuberculosis APIs Company Information
 Table 166. Maneesh Pharmaceuticals Ltd. Anti-tuberculosis APIs Specification and Application
 Table 167. Maneesh Pharmaceuticals Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 168. Maneesh Pharmaceuticals Ltd. Main Business and Markets Served
 Table 169. Maneesh Pharmaceuticals Ltd. Recent Developments/Updates
 Table 170. Wuhan Wuyao Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Company Information
 Table 171. Wuhan Wuyao Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Specification and Application
 Table 172. Wuhan Wuyao Pharmaceutical Co., Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 173. Wuhan Wuyao Pharmaceutical Co., Ltd. Main Business and Markets Served
 Table 174. Wuhan Wuyao Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 175. Cadila Pharmaceuticals Anti-tuberculosis APIs Company Information
 Table 176. Cadila Pharmaceuticals Anti-tuberculosis APIs Specification and Application
 Table 177. Cadila Pharmaceuticals Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 178. Cadila Pharmaceuticals Main Business and Markets Served
 Table 179. Cadila Pharmaceuticals Recent Developments/Updates
 Table 180. Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Company Information
 Table 181. Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Specification and Application
 Table 182. Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 183. Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Main Business and Markets Served
 Table 184. Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 185. PKU HealthCare Corp., Ltd. Anti-tuberculosis APIs Company Information
 Table 186. PKU HealthCare Corp., Ltd. Anti-tuberculosis APIs Specification and Application
 Table 187. PKU HealthCare Corp., Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 188. PKU HealthCare Corp., Ltd. Main Business and Markets Served
 Table 189. PKU HealthCare Corp., Ltd. Recent Developments/Updates
 Table 190. Northeast Pharmaceutical Group Co., Ltd. Anti-tuberculosis APIs Company Information
 Table 191. Northeast Pharmaceutical Group Co., Ltd. Anti-tuberculosis APIs Specification and Application
 Table 192. Northeast Pharmaceutical Group Co., Ltd. Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 193. Northeast Pharmaceutical Group Co., Ltd. Main Business and Markets Served
 Table 194. Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 195. Godavari Drugs Limited Anti-tuberculosis APIs Company Information
 Table 196. Godavari Drugs Limited Anti-tuberculosis APIs Specification and Application
 Table 197. Godavari Drugs Limited Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 198. Godavari Drugs Limited Main Business and Markets Served
 Table 199. Godavari Drugs Limited Recent Developments/Updates
 Table 200. Camus Pharma Anti-tuberculosis APIs Company Information
 Table 201. Camus Pharma Anti-tuberculosis APIs Specification and Application
 Table 202. Camus Pharma Anti-tuberculosis APIs Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 203. Camus Pharma Main Business and Markets Served
 Table 204. Camus Pharma Recent Developments/Updates
 Table 205. Key Raw Materials Lists
 Table 206. Raw Materials Key Suppliers Lists
 Table 207. Anti-tuberculosis APIs Distributors List
 Table 208. Anti-tuberculosis APIs Customers List
 Table 209. Anti-tuberculosis APIs Market Trends
 Table 210. Anti-tuberculosis APIs Market Drivers
 Table 211. Anti-tuberculosis APIs Market Challenges
 Table 212. Anti-tuberculosis APIs Market Restraints
 Table 213. Research Programs/Design for This Report
 Table 214. Key Data Information from Secondary Sources
 Table 215. Key Data Information from Primary Sources
 Table 216. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-tuberculosis APIs
 Figure 2. Global Anti-tuberculosis APIs Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Anti-tuberculosis APIs Market Share by Type: 2024 VS 2031
 Figure 4. Pyrazinamide APIs Product Picture
 Figure 5. Isoniazid APIs Product Picture
 Figure 6. Rifampicin APIs Product Picture
 Figure 7. Ethambutol HCL APIs Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Anti-tuberculosis APIs Market Value by Application, (US$ Million) & (2020-2031)
 Figure 10. Global Anti-tuberculosis APIs Market Share by Application: 2024 VS 2031
 Figure 11. Tablets
 Figure 12. Capsules
 Figure 13. Other
 Figure 14. Global Anti-tuberculosis APIs Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Anti-tuberculosis APIs Production Value (US$ Million) & (2020-2031)
 Figure 16. Global Anti-tuberculosis APIs Production Capacity (Tons) & (2020-2031)
 Figure 17. Global Anti-tuberculosis APIs Production (Tons) & (2020-2031)
 Figure 18. Global Anti-tuberculosis APIs Average Price (US$/Ton) & (2020-2031)
 Figure 19. Anti-tuberculosis APIs Report Years Considered
 Figure 20. Anti-tuberculosis APIs Production Share by Manufacturers in 2024
 Figure 21. Global Anti-tuberculosis APIs Production Value Share by Manufacturers (2024)
 Figure 22. Anti-tuberculosis APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. The Global 5 and 10 Largest Players: Market Share by Anti-tuberculosis APIs Revenue in 2024
 Figure 24. Global Anti-tuberculosis APIs Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 25. Global Anti-tuberculosis APIs Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 26. Global Anti-tuberculosis APIs Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 27. Global Anti-tuberculosis APIs Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 28. North America Anti-tuberculosis APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Europe Anti-tuberculosis APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. China Anti-tuberculosis APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 31. Japan Anti-tuberculosis APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. Global Anti-tuberculosis APIs Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 33. Global Anti-tuberculosis APIs Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 34. North America Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. North America Anti-tuberculosis APIs Consumption Market Share by Country (2020-2031)
 Figure 36. U.S. Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. Canada Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. Europe Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Europe Anti-tuberculosis APIs Consumption Market Share by Country (2020-2031)
 Figure 40. Germany Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. France Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. U.K. Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Italy Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Russia Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Asia Pacific Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Asia Pacific Anti-tuberculosis APIs Consumption Market Share by Region (2020-2031)
 Figure 47. China Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. Japan Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. South Korea Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. China Taiwan Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Southeast Asia Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. India Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Latin America, Middle East & Africa Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Latin America, Middle East & Africa Anti-tuberculosis APIs Consumption Market Share by Country (2020-2031)
 Figure 55. Mexico Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. Brazil Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Turkey Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 58. GCC Countries Anti-tuberculosis APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 59. Global Production Market Share of Anti-tuberculosis APIs by Type (2020-2031)
 Figure 60. Global Production Value Market Share of Anti-tuberculosis APIs by Type (2020-2031)
 Figure 61. Global Anti-tuberculosis APIs Price (US$/Ton) by Type (2020-2031)
 Figure 62. Global Production Market Share of Anti-tuberculosis APIs by Application (2020-2031)
 Figure 63. Global Production Value Market Share of Anti-tuberculosis APIs by Application (2020-2031)
 Figure 64. Global Anti-tuberculosis APIs Price (US$/Ton) by Application (2020-2031)
 Figure 65. Anti-tuberculosis APIs Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Oncology API Market Research Report 2024
Global NSAID API Market Research Report 2024
Global Pyrazinamide APIs Market Research Report 2025
Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rifampicin API Market Research Report 2025
Global Isoniazid APIs Market Research Report 2025
Global Ethambutol Hydrochloride API Market Research Report 2025
Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025
Global Natural APIs Active Pharmaceutical Ingredients Market Research Report 2024
Global Antiinfective API Market Research Report 2024
Global Anti retroviral APIs Market Research Report 2024
Global Therapeutic Peptide APIs Market Research Report 2024
Global Nonsteroidal Anti inflammatory APIs Market Research Report 2024
Global Cytotoxic Active Pharmaceutical Ingredients API Market Research Report 2025
Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030
Tuberculosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiviral API Lamivudine TDF and TAF Market Research Report 2024
Anti Tuberculosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Active Pharmaceutical Ingredients API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fermentation derived Antibiotic APIs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions